About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Use of Beta-blockers Before Coronary Artery Bypass Grafting Surgery Not Linked to Better Outcomes

by Dr. Enozia Vakil on June 18, 2014 at 2:11 PM
Font : A-A+

 Use of Beta-blockers Before Coronary Artery Bypass Grafting Surgery Not Linked to Better Outcomes

Use of beta blockers for patients undergoing nonemergency coronary artery bypass surgery is not linked to better outcomes, according to a new study.

William Brinkman, M.D., of the Cardiopulmonary Research Science and Technology Institute, Dallas, and colleagues.

Advertisement

The use of preoperative β-blockers has been associated with a reduction in perioperative mortality for patients undergoing CABG surgery in previous observational studies. Preoperative β-blocker therapy is a national quality standard.

How the Study Was Conducted: The authors conducted a retrospective analysis of the Society of Thoracic Surgeons National Adult Cardiac database of U.S. hospitals performing cardiac surgery from 2008 to 2012. The study included 506,110 patients undergoing nonemergency CABG surgery who had not had a heart attack in the previous 21 days or any other high-risk symptoms.
Advertisement

Of the 506,110 patients, 86.2 percent received preoperative β-blockers within 24 hours of surgery. The authors found no difference between patients who did and did not receive preoperative β-blockers in rates of death due to the operation, stroke, prolonged ventilation, any reoperation, renal failure and deep sternal wound infection. Patients who received preoperative β-blockers did have higher rates of new-onset atrial fibrillation than patients who did not.

Blockers are an important and effective tool in the care of patients undergoing cardiac surgery in specific clinical scenarios. However, the empirical use of β-blockers as recommended by the National Quality Forum (without physiologic goals i.e., adequate clinical drug levels) in all patients before CABG may not improve outcomes. A prospective randomized trial with careful attention to adequate dosing and specific drug type may help to answer this question."



Source: Eurekalert
Advertisement

Advertisement
Advertisement

Recommended Reading

Latest Research News

How Does a New Procedure Help Patients Avoid Leg Amputation?
Limb savage procedure benefits patients with severe vascular disease who are at risk for amputation of their limbs.
Omega-3 Can Save Alzheimer's Patients from Vision Loss
Does omega-3 help Alzheimer's patients? A new form of omega-3 helped restore specific markers of eye health in mice bred with aspects of early-onset Alzheimer's disease.
Why Is Asthma Linked to Increased Risk of Osteoarthritis?
Drugs used to inhibit the physiological responses for allergic reactions lessen osteoarthritis risk, revealed research.
 Experiments on Child Brain Tumour and Muscle Ageing Heading to Space
The International Space Station will be used to carry out experiments seeking to improve understanding of incurable child brain tumors and the muscle aging process.
 Nearly 1 In 5 UK Adults Experience Negative Responses to Sounds
How many people in the UK have misophonia? In a representative sample study, most people had at least some irritation upon hearing trigger sounds.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Use of Beta-blockers Before Coronary Artery Bypass Grafting Surgery Not Linked to Better Outcomes Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests